Drug Shortage Report for RIVA-RIZATRIPTAN ODT
| Report ID | 8435 |
| Drug Identification Number | 02423464 |
| Brand name | RIVA-RIZATRIPTAN ODT |
| Common or Proper name | Riva-Rizatriptan ODT |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RIZATRIPTAN |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL |
| Packaging size | 6 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-04-28 |
| Actual start date | 2017-04-28 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2018-12-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2017-04-29 | English | Compare |
| v2 | 2017-04-28 | French | Compare |
| v1 | 2017-04-28 | English | Compare |
Showing 1 to 3 of 3